Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H I - J - K - L - M N - O - P - Q - R - S T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter A

GENERIC NAME

TRADE NAME

CONDITION

STUDY CODE

STUDY NAME

ACCESS TO STUDY / PROTOCOL

ACCESS TO RESULTS

AAV2-SFLT01

Not Marketed

Age-Related Macular Degeneration 

MSC12870

NA

NCT01024998

ABCA4 GENE THERAPY

Not Marketed

Stargardt's Disease

TDU13583

NA

EudraCT: 2010-023111-34

AFLIBERCEPT

Zaltrap

Cancer

TES10897

QUTIE

EudraCT: 2008-006796-80

AFLIBERCEPT

Zaltrap

Cancer

ARD6122

NA

NCT00327171

AFLIBERCEPT

Zaltrap

Cancer

ARD6123

NA

NCT00284141

AFLIBERCEPT

Zaltrap

Cancer

EFC6125

NA

NCT00327444

AFLIBERCEPT

Zaltrap

Cancer

EFC6546

NA

NCT00519285

AFLIBERCEPT

Zaltrap

Cancer

ARD6772

NA

NCT00396591

AFLIBERCEPT

Zaltrap

Cancer

EFC10262

VELOUR

NCT00561470

  • Tabulated Results

AFLIBERCEPT

Zaltrap

Cancer

EFC10261

VITAL

NCT00532155

AFLIBERCEPT

Zaltrap

Cancer

EFC10547

VANILLA

NCT00574275

AFLIBERCEPT

Zaltrap

Cancer

EFC10668

AFFIRM

NCT00851084

AFLIBERCEPT

Zaltrap

Cancer

EFC10668

AFFIRM

NCT00851084

AFLIBERCEPT

Zaltrap

Cancer

TCD11382

NA

NCT01148615

AFLIBERCEPT

Zaltrap

Cancer

TCD11470

NA

NCT01930552

AFLIBERCEPT

Zaltrap

Colorectal cancer

AFLIBC06561

AMOR

NCT01955629

AFLIBERCEPT

Zaltrap

Cancer

TCD6117

NA

NA

AFLIBERCEPT

Zaltrap

Colorectal cancer

EFC11338

AFLAME

NCT01661270

AFLIBERCEPT

Zaltrap

Colorectal cancer

EFC11885

NA

NCT01882868

AFLIBERCEPT

Zaltrap

Non Hodgkins Lymphoma

TCD10173

NA

NCT00644124

AFLIBERCEPT

Zaltrap

Colorectal cancer

AFLIBL06266

AFEQT

NCT01670721

AFLIBERCEPT

Zaltrap

Colorectal cancer

AFLIBC06097

NA

EudraCT: 2011-005724-17

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL-005-99

NA

NCT00074971

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL-006-99*

NA

 

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL-007-99*

NA

 

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL-008-00

NA

NCT00074984

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL-016-01

NA

NCT00074958

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL-017-01

NA

NCT00196716

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL-019-01*

NA

 

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL-022-02

NA

NCT00837824

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL02503

NA

NCT00081497

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL06207

FIELD

NCT00701415

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL03204

NA

NCT00140621

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL-1-002-98*

NA

 

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL19110

NA

EudraCT: 2012-001966-14

AGALSIDASE BETA

Fabrazyme

Fabry Disease

AGAL19412

NA

NCT01650779

AGALSIDASE BETA

Fabrazyme

Fabry Disease

DIREGC07006

NA

NCT00196742

AGALSIDASE BETA

Fabrazyme

Fabry Disease

FB9702-01*

NA

 

ALEMTUZUMAB

Campath

Leukemia

CAM203

NA

NCT00328198

ALEMTUZUMAB

Campath

Leukemia

CAM211*

NA

 

ALEMTUZUMAB

Campath

Leukemia

CAM307*

NA

NCT00046683

ALEMTUZUMAB

Campath

Leukemia

CAM314

NA

NCT00086580

ALEMTUZUMAB

Lemtrada

Multiple Sclerosis

ALEMLL08091

LemCourse

EudraCT: 2016-000464-42

ALEMTUZUMAB

Lemtrada

Multiple Sclerosis

ASY15905

LEMTRADA-ITP

NCT03784898

ALEMTUZUMAB

Lemtrada

Multiple Sclerosis

CAMMS223

NA

NCT00050778

ALEMTUZUMAB

Lemtrada

Multiple Sclerosis

CAMMS323

CARE-MS I

NCT00530348

ALEMTUZUMAB

Lemtrada

Multiple Sclerosis

CAMMS32400507

CARE-MS II

NCT00548405

ALEMTUZUMAB

Lemtrada

Multiple Sclerosis

CAMMS03409

CARE-MS II

NCT00548405

ALEMTUZUMAB

Lemtrada

Multiple Sclerosis

LPS13649

TOPAZ

NCT02255656

ALEMTUZUMAB

Lemtrada

Multiple Sclerosis

LPS13650

EMERALD

EudraCT: 2014-000092-62

ALEMTUZUMAB

Lemtrada

Multiple Sclerosis

TDU14260

SCALA

NCT02583594

ALEMTUZUMAB

Not Marketed

Multiple Sclerosis

TDU13475

NA

NCT02282826

ALEMTUZUMAB

Not Marketed

Multiple Sclerosis

TDU14981

NA

NCT02977533

ALFUZOSIN

Uroxatral, Xatral

Prostatic Diseases

ALFUS_L_01241

SAMBA_THAILAND

NCT00401661

ALFUZOSIN

Uroxatral, Xatral

Prostatic Diseases

ALFUS_L_01667

SAMBA

NCT00486785

ALFUZOSIN

Uroxatral, Xatral

Benign Prostatic Hyperplasia

DRI5234

NA

NCT00409357

ALFUZOSIN

Uroxatral, Xatral

Benign Prostatic Hyperplasia

EFC4428

ALFAURUS

NCT00290030

ALFUZOSIN

Uroxatral, Xatral

Benign Prostatic Hyperplasia

EFC4485

NA

NCT00029822

ALFUZOSIN

Uroxatral, Xatral

Neurogenic Urinary Bladder

EFC5722

ALPHACHIN

NCT00549939

ALFUZOSIN

Uroxatral, Xatral

Benign Prostatic Hyperplasia

EFC5791

NA

NCT00399464

ALFUZOSIN

Uroxatral, Xatral

Hydronephosis Neurogenic Bladder

EFC6269

ALPHAHYDRO

NCT00576823

ALFUZOSIN

Uroxatral, Xatral

Prostatic Diseases

L_8472

ALF-ACUTE

NCT00540891

ALFUZOSIN

Uroxatral, Xatral

Prostatic Diseases

L_8758

NA

NCT00637715

ALFUZOSIN

Uroxatral, Xatral

Prostatic Diseases

L_8819

NA

NCT00542165

ALFUZOSIN

Uroxatral, Xatral

Prostatic Diseases

L_8935

ALEX-XL

NCT00575913

ALFUZOSIN

Uroxatral, Xatral

Urologic Diseases

L_9397

ALF-RIK

NCT00453908

ALFUZOSIN

Uroxatral, Xatral

Prostatic Diseases

L_9645

NA

NCT00336921

ALFUZOSIN

Uroxatral, Xatral

Calculi

L_9795

ALF-STONE

EudraCT: 2005-005481-36

ALFUZOSIN

Uroxatral, Xatral

Benign Prostatic Hyperplasia

LTS5235

NA

NCT00347061

ALFUZOSIN

Uroxatral, Xatral

Urinary Bladder Neurogenic

PKM6270

ALPHACHIP

NCT00629720

ALFUZOSIN

Uroxatral, Xatral

Prostatic Diseases

PM_L_0168

ALFONE CHINA

NCT00280605

ALGLUCOSIDASE ALFA

Lumizyme

Pompe Disease Glycogen Storage Disease Type II (GSD II)

MSC12790/ AGLU07710

PAPAYA

2010-022231-11

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU01602

NA

NCT00059280

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU01702

NA

EudraCT: 2004-002168-59

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU02704

NA

NCT00158600

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU02804

NA

EudraCT: 2005-002829-31

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU03206

NA

NCT00455195

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU03306

NA

NCT00483379

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU03707_MSC12817

NA

EudraCT: 2015-000583-34

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU03807

NA

NCT00701129

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU07310

NA

NCT01288027

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU07510

NA

NCT01597596

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

AGLU09411

NA

NCT01526785

ALGLUCOSIDASE ALFA

Myozyme

Pompe Disease

ALGMYL08718

APOLLO-IOPD

EudraCT: 2021-004047-25

ALGLUCOSIDASE ALFA

Myozyme® Lumizyme®

Pompe Disease; Glycogen Storage Disease Type II (GSD II); Acid Maltase Deficiency Disease

LTS12869

NA

NCT00486889

ALIROCUMAB

Praluent

Acute Coronary Syndrome

ALIROL08069

ODYSSEY J-IVUS

NCT02984982

ALIROCUMAB

Praluent

Hypercholesterolemia

DFI11565

NA

NCT01288443

ALIROCUMAB

Praluent

Hypercholesterolemia

DFI11566

NA

NCT01288469

ALIROCUMAB

Praluent

Hypercholesterolemia

DFI12361

NA

NCT01812707

ALIROCUMAB

Praluent

Hypercholesterolemia

DFI14223

ODYSSEY KIDS

EudraCT: 2015-003766-85

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC14074

NA

NCT02289963

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC11568

ODYSSEY COMBO I

NCT01644175

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC11569

ODYSSEY COMBO II

NCT01644188

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC11716

ODYSSEY MONO

NCT01644474

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC12492

ODYSSEY FH I

NCT01623115

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC12732

ODYSSEY HIGH FH

NCT01617655

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC13672

ODYSSEY JAPAN

NCT02107898

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC13786

ODYSSEY CHOICE II

NCT02023879

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC13889

ODYSSEY EAST

NCT02715726

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC14305

ODYSSEY-NIPPON

NCT02584504

ALIROCUMAB

Praluent

Hypercholesterolemia

EFC14660

NA

NCT03510715

ALIROCUMAB

Praluent

Dyslipidemia

LPS14354

ODYSSEY DM-Dyslipidemia

NCT02642159

ALIROCUMAB

Praluent

Hypercholesterolemia

LPS14245

ODYSSEY APPRISE

NCT02476006

ALIROCUMAB

Praluent

Hypercholesterolemia

LPS14355

ODYSSEY DM-Insulin

NCT02585778

ALIROCUMAB

Praluent

Hypercholesterolemia

LTS11717

ODYSSEY LONG TERM

NCT01507831

ALIROCUMAB

Praluent

Hypercholesterolemia

LTS13463

ODYSSEY OLE

EudraCT: 2013-002572-40

ALIROCUMAB

Praluent

Hypercholesterolemia

MSC14864

NA

NCT03415178

ALIROCUMAB

Praluent

Hypercholesterolemia

POP12671

NA

NCT01670734

ALIROCUMAB

Praluent

Cardiovascular Diseases

EFC11570

NA

NCT01663402

AMBROXOL

Not marketed

Acute Pharyngitis

LPS15328

DELICIOUS

NCT03583658

Amcenestrant

Not marketed

Breast Cancer

ACT16106

AMEERA-4

NCT04191382

AMIBEGRON

Not marketed

Major Depressive Disorder

EFC4846

ZEPHIR

NCT00319709

AMIBEGRON

Not marketed

Major Depressive Disorder

EFC5041

ORION

NCT00252356

AMIBEGRON

Not marketed

Major Depressive Disorder

EFC5116

PHOENIX

NCT00252330

AMIBEGRON

Not marketed

Major Depressive Disorder

EFC5374

NA

NCT00825058

AMIBEGRON

Not marketed

Major Depressive Disorder

EFC5379

NA

NCT00825019

AMIBEGRON

Not marketed

Generalized anxiety disorder

EFC5891

ELECTRA

EudraCT: 2005-003180-23

AMIBEGRON

Not marketed

Generalized anxiety disorder

EFC5892

LIBRA

NCT00252343

AMIBEGRON

Not marketed

Generalized anxiety disorder

EFC5893

AQUARIUS

EudraCT: 2005-003181-41

AMIBEGRON

Not marketed

Generalized anxiety disorder

EFC5895

GEMINI

EudraCT: 2006-004147-33

AMIBEGRON

Not marketed

Major Depressive Disorder

EFC6224

ALBERIO

EudraCT: 2006-004146-16

AMIBEGRON

Not marketed

Major Depressive Disorder

EFC6607

SIRIUS

NCT00385307

AMIBEGRON

Not marketed

Major Depressive Disorder

LTE5376

CALYPSO

EudraCT: 2005-004006-81

AMIBEGRON

Not marketed

Generalized anxiety disorder

LTE5894

VEGA

EudraCT: 2006-002253-71

AMIBEGRON

Not marketed

Major Depressive Disorder

LTS4848

NA

EudraCT: 2005-000577-21

AMISULPRIDE

Solian

Schizophrenia

AMISU_L_01008

AMIMIND

EudraCT: 2007-005772-13

AMISULPRIDE

Solian

Bipolar Disorder

C_8428

SOLMANIA

NCT00126009

AMISULPRIDE

Solian

Schizophrenia

L_8967

AMIRISMIND

NA

AMISULPRIDE

Solian

Schizophrenia

L_8968

NA

NCT00331981

AMISULPRIDE

Solian

Schizophrenia

L_9517

ASAP

NCT00436371

AMISULPRIDE

Solian

Schizophrenia

PM_L_0055

SOLIACS

EudraCT: 2004-004461-15

AMISULPRIDE

Solian

Schizophrenia

AMISUL06155

ESCAPE

NCT01795183

AMLITELIMAB

Not marketed

Atopic Dermatitis

ACT17369

NA

EudraCT: 2018-002299-41

ANTIBODY DRUG CONJUGATE

Not Marketed

Neoplasm Malignant

TED14147

NA

NCT02575781

ANTIBODY-DRUG CONJUGATE TARGETING SIALOGLYCOTOPE CA6/HUDS6

Not Marketed

Triple Negative Breast Cancer

TED10499

NA

NCT01156870

ANTI-CXCR5 MAB

Not Marketed

Systemic Lupus Erythematosus

TDR11407

NA

NCT02321709

ANTI-PNAG MONOCLONAL ANTIBODY

Not marketed

Infection prophylaxis

PKD11791

NA

NCT01389700

ANTI-THYMOCYTE GLOBULIN (RABBIT)

Thymoglobulin

kidney transplant rejection

SANG-93-3-K-THY-R*

NA

 

ANTI-THYMOCYTE GLOBULIN (RABBIT)

Thymoglobulin

kidney transplant rejection

SANG-96-3-K-THY-I*

NA

 

ANTI-THYMOCYTE GLOBULIN (RABBIT)

Thymoglobulin

kidney transplant rejection

SMC-101-1002*

NA

 

ANTI-THYMOCYTE GLOBULIN (RABBIT)

Thymoglobulin

kidney transplant rejection

SMC-101-1007*

NA

 

ANTI-THYMOCYTE GLOBULIN (RABBIT)

Thymoglobulin

kidney transplant rejection

SMC-101-1008*

NA

 

ANTI-THYMOCYTE GLOBULIN (RABBIT)

Thymoglobulin

kidney transplant rejection

SMC-101-1009*

NA

 

ANTI-THYMOCYTE GLOBULIN (RABBIT)

Thymoglobulin

kidney transplant rejection

SMC-534-1003*

NA

 

ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN

Eloctate

Hemophilia A

EFC16225 (997HA306)

NA

NCT02234323

ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN

Eloctate

Hemophilia A

LPS16473

verITI-8 Study

NCT03093480

Alogliptin

Nesina

Diabetes Mellitus, Type 2

ALOGLC08867

ACADEMIC

NCT03794336

ARTESUNATE

Arsucam

Malaria

ARTEN_L_00848

ACT MALI

NCT00452907

ARTESUNATE

Arsucam

Malaria

PM_L_0163

ATOL

NCT00445796

ARTESUNATE + AMODIAQUINE

Coarsucam

Malaria

ARAMF_L_01570

NA

NCT00386503

ARTESUNATE + AMODIAQUINE

Coarsucam

Malaria

ARAMF_L_02873

NA

NCT00540410

ARTESUNATE + AMODIAQUINE

Coarsucam

Malaria

PM_L_0164

ATAQ EASY

NCT00316329

ARTESUNATE + AMODIAQUINE

Coarsucam

Malaria

ARAMF_L_02661

NA

NCT00699920

ARTESUNATE + AMODIAQUINE

Coarsucam

Malaria

ARAMF_C_05370

NA

NCT01378286

ARTESUNATE + AMODIAQUINE

Coarsucam

Malaria

ARAMF_L_04314

NA

NCT01023399

ATACIGUAT

Not marketed

Pain, Neuropathic

DFI10569

SERENEATI

EudraCT: 2008-001518-26

ATACIGUAT

Not marketed

Peripheral Arterial Disease

DFI6174

ACCELA

NCT00443287

ATORVASTATIN/IRBESARTAN

Rovelito

Diabetes Mellitus, Type 2

ATOIRL07827

NA

NCT02842359

AVANAFIL

Spedra

Erectile Dysfuntion

AVANAL07163

CEDAR

NCT02503306


References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted